Correlation of Specific Inflammatory Markers With the Occurrence of Depression in Patients With Psoriasis and Their Use as Biomarkers for the Diagnosis of Depression
- PMID: 38810053
- PMCID: PMC11135957
- DOI: 10.5826/dpc.1402a104
Correlation of Specific Inflammatory Markers With the Occurrence of Depression in Patients With Psoriasis and Their Use as Biomarkers for the Diagnosis of Depression
Abstract
Introduction: Psoriasis is a systemic disease of the skin and nails associated with a wide range of comorbidities such as depression, psoriatic arthritis and metabolic syndrome.
Objectives: The study aimed to examine a potential association between inflammatory markers (C- reactive protein [CRP] and erythrocyte sedimentation rate [ESR]) and depression in patients with psoriasis.
Methods: A total of 80 individuals were enrolled in the study. Case participants included 28 patients diagnosed with Psoriasis (Beck Depression Inventory-II: :0-13) and 24 patients diagnosed with Psoriasis and Depression (Beck Depression Inventory-II:14-63). Twenty-eight (28) healthy participants comprised the control group.Psoriasis severity was evaluated by using Psoriasis Area and Severity Index, Physician Global Assessment, Body Surface Area and Dermatology Life Quality Index. Written approval was obtained for its use in this study: Cardiff University (09/2015). Other factors considered in the study were obesity using the Body Mass Index, the levels of stress using the Beck Anxiety Inventory, and the presence of insomnia using the Athens Insomnia Scale. Blood draws and inflammatory markers measurements were performed for all participants.
Results: Both CRP and ESR levels were higher in the case group (ie Psoriasis and Depression and Psoriasis) compared to healthy controls. Furthermore, psoriatic patients with depression showed increased CRP and ESR levels compared to those of psoriatic patients without depression.
Conclusions: The evaluation of both CRP and ESR and their use to detect the presence of depression in patients with psoriasis can be an important tool for their holistic treatment of theirs.
Conflict of interest statement
Figures
Similar articles
-
Elevated C-Reactive Protein and Erythrocyte Sedimentation Rate Correlates with Depression in Psoriasis: A Chinese Cross-Sectional Study.Clin Cosmet Investig Dermatol. 2023 Feb 13;16:397-405. doi: 10.2147/CCID.S401934. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 36817640 Free PMC article.
-
[Association of skin lesion severity with clinical features of psoriatic arthritis].Zhonghua Nei Ke Za Zhi. 2022 Jul 1;61(7):779-784. doi: 10.3760/cma.j.cn112138-20220302-00152. Zhonghua Nei Ke Za Zhi. 2022. PMID: 35764561 Chinese.
-
Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1186-91. doi: 10.1111/jdv.12255. Epub 2013 Aug 24. J Eur Acad Dermatol Venereol. 2014. PMID: 23981008
-
Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set.J Rheumatol. 2019 Mar;46(3):266-273. doi: 10.3899/jrheum.180195. Epub 2018 Nov 1. J Rheumatol. 2019. PMID: 30385708
-
Research gaps in psoriasis: opportunities for future studies.J Am Acad Dermatol. 2014 Jan;70(1):146-67. doi: 10.1016/j.jaad.2013.08.042. Epub 2013 Oct 11. J Am Acad Dermatol. 2014. PMID: 24126079 Review.
Cited by
-
Prevalence of Psychiatric and Addictive Disorders in Patients with Psoriasis: A Cross-Sectional Study.Diagnostics (Basel). 2025 May 14;15(10):1231. doi: 10.3390/diagnostics15101231. Diagnostics (Basel). 2025. PMID: 40428224 Free PMC article.
-
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions.Am J Clin Dermatol. 2025 Jan;26(1):35-43. doi: 10.1007/s40257-024-00905-9. Epub 2024 Dec 2. Am J Clin Dermatol. 2025. PMID: 39623152 Review.
-
Molecular Link Between Psoriasis and Depression-Update on Pathophysiology.Int J Mol Sci. 2025 Mar 10;26(6):2467. doi: 10.3390/ijms26062467. Int J Mol Sci. 2025. PMID: 40141110 Free PMC article. Review.
References
-
- Global report on psoriasis. World Health Organization; Oct 26, 2016. p. 10.
-
- PrCEMGriffiths MD, et al. Psoriasis, lancet. 2021 april 3;397
-
- Palijan TZ, Kovacević D, Koić E, Ruzić K, Dervinja F. The impact of psoriasis on the quality of life and psychological characteristics of persons suffering from psoriasis. Coll Antropol. 2011;35(Suppl 2):81–85. - PubMed
-
- Han C, Lofland JH, Zhao N, Schenkel B. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis. J Drugs Dermatol. 2011;10(8):843–850. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous